Vivimed Labs Financials

NSE: VIVIMEDLAB | BSE: 532660

₹6.58

up-down-arrow0.04 (0.61%)

As on 04-Sep-2026 15:54IST

Market cap

info icon

₹55 Cr

Revenue (TTM)

info icon

₹70 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.2

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Operating Revenue
69.99
116.27
149.07
187.10
237.29
861.47
Total Income
76.33
120.64
159.05
188.07
238.56
871.29
Total Expenditure
222.43
129.28
181.95
374.09
245.11
829.59
EBITDA
-152.44
-13.01
-32.87
-186.99
-7.83
31.88
Depreciation
26.05
20.23
19.94
108.41
18.28
55.50
EBIT
-178.49
-33.24
-52.82
-295.39
-26.11
-23.62
Interest
4.18
2.98
2.98
36.23
39.99
56.06
Other Income
6.34
4.37
9.98
0.97
1.27
9.82
Exceptional Items
--
--
--
--
--
--
Profit before Tax
-176.33
-31.85
-45.82
-330.65
-64.83
-69.86
Provision for Tax
0.14
0.11
-0.38
-2.12
2.82
2.03
Profit after Tax
-176.47
-31.96
-45.45
-328.54
-67.65
-71.89
Minority Interest
--
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
-176.47
-31.96
-45.45
-328.54
-67.65
-71.89

Liabilities (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Shareholder's Funds
-210.55
-35.17
-5.46
39.42
364.29
431.58
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
515.92
547.81
545.61
531.54
528.34
516.68
Current Liabilities
448.11
408.21
410.71
424.25
373.39
341.08
Total Liabilities
753.48
920.85
950.86
995.21
1,266.01
1,289.33

Assets (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Non-Current Assets
583.95
593.28
607.89
656.06
758.75
760.62
Current Assets
168.00
327.57
342.97
339.14
507.27
528.71
Total Assets
753.48
920.85
950.86
995.21
1,266.01
1,289.33
Total Debt*
--
376.33
376.93
378.57
358.88
325.62
Net Current Assets
-280.11
-80.64
-67.74
-85.10
133.88
187.63
Contingent Liabilities
--
182.90
115.79
122.93
215.57
220.66

Cashflow (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Cash From Operating Activities
--
-1.75
-23.99
35.32
27.54
567.28
Cash Flow from Investing Activities
--
-4.53
28.29
-4.97
-16.41
404.00
Cash from Financing Activities
--
4.96
-6.03
-33.78
-10.38
-1,015.33
Net Cash Inflow / Outflow
--
-1.32
-1.74
-3.42
0.75
-44.06

Financials Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Adjusted EPS (₹) info
-21.28
-3.85
-5.48
-39.62
-8.16
-8.67
Cash EPS (₹) info
-21.28
-1.42
-3.08
-26.55
-5.95
-1.98
Adjusted Book Value (₹) info
-30.11
-8.82
-5.24
0.17
39.35
47.47
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
-0.21
-2.89
4.26
3.32
68.42
Free Cash Flow per Share (₹) info
--
-1.16
-3.38
-0.41
-3.86
59.36

Profitability Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
ROCE (%) info
--
-9.07
-12.01
-55.28
-3.54
-1.12
ROE (%) info
--
--
--
-200.51
-18.80
-16.62
ROA (%) info
-21.08
-3.42
-4.67
-29.06
-5.29
-4.13
EBIT Margin (%) info
-255.02
-28.59
-35.43
-157.88
-11.00
-2.74
Net Margin (%) info
-231.21
-26.49
-28.57
-174.69
-28.36
-8.25
Cash Profit Margin (%) info
0.00
-10.09
-17.11
-117.65
-20.80
-1.90

Growth Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Revenue Growth (%) info
-39.80
-22.00
-20.33
-21.15
-72.46
-18.64
EBIT Growth (%) info
-436.45
37.07
82.12
-1,031.34
-10.56
60.90
Net Profit Growth (%) info
-452.15
29.67
86.17
-385.64
5.89
34.12
EPS Growth (%) info
-452.15
29.67
86.17
-385.64
5.89
34.12
Book Value Growth (%) info
--
-68.36
-3,156.33
-99.56
-17.10
-16.50

Valuation Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Price / Earnings info
-0.31
--
--
--
--
--
Price / Book Value info
-0.22
--
--
38.89
0.37
0.33
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
-3.09
-45.38
-17.10
-2.31
-71.91
10.81
Close Price (₹) info
5.28
--
--
6.60
14.50
16.10
High Price (₹) info
29.40
--
--
17.40
41.50
23.62
Low Price (₹) info
5.26
--
--
6.60
14.25
7.25
Market Cap (₹ Cr) info
55.30
--
--
55.31
119.81
131.46

Solvency Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Debt to Equity info
-0.34
-5.14
-8.67
266.22
1.10
0.83
Short term debt to equity ratio info
--
-8.89
-57.38
5.70
0.60
0.45
Current Ratio info
0.37
0.80
0.84
0.80
1.36
1.55
Quick Ratio info
0.35
0.66
0.68
0.61
0.71
0.80
Interest Coverage info
-41.16
-9.69
-14.36
-8.13
-0.62
-0.25

Operating Efficiency Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Debtors to sales (%) info
64.77
63.74
55.56
39.63
36.82
12.48
Asset Turnover info
0.08
0.12
0.15
0.17
0.19
0.49
Receivable days info
--
246.32
192.18
157.55
149.87
75.54
Inventory Days info
--
192.78
176.07
312.65
381.82
160.49
Payable days info
--
254.58
253.55
65.28
90.54
134.23
Cash Conversion Cycle info
--
184.52
114.70
404.91
441.16
101.80
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...